Malignant mesothelioma is a primary cancer of the serosal cavities, an anatomic site that is also frequently affected by metastatic disease, predominantly from primary carcinomas of the lung, breast, and ovary. Advances in immunohistochemistry have resulted in improved diagnostic sensitivity and specificity in the differential diagnosis between metastatic adenocarcinoma and malignant mesothelioma in both cytological and histological material. This abstract presents some data regarding the diagnostic and biological aspects of malignant mesothelioma.
32th European Congress of Cytolotgy / Vetrani, Antonio. - (2006). (Intervento presentato al convegno 32th European Congress of Cytolotgy tenutosi a Venezia nel 1-4 ottobre 2006).
32th European Congress of Cytolotgy
VETRANI, ANTONIO
2006
Abstract
Malignant mesothelioma is a primary cancer of the serosal cavities, an anatomic site that is also frequently affected by metastatic disease, predominantly from primary carcinomas of the lung, breast, and ovary. Advances in immunohistochemistry have resulted in improved diagnostic sensitivity and specificity in the differential diagnosis between metastatic adenocarcinoma and malignant mesothelioma in both cytological and histological material. This abstract presents some data regarding the diagnostic and biological aspects of malignant mesothelioma.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
